PMCF Study on the Safety, Performance and Clinical Benefits Data of the Zimmer® Plates and Screws System
Launched by ZIMMER BIOMET · Jan 28, 2022
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
The Zimmer® Plates and Screws System consists of temporary internal fixation devices comprised of plates and screws that provide management of fractures through interfragmentary compression and bone plating. In this study, the focus is on the Zimmer® Plates and Screws System used to stabilize diaphyseal, proximal humerus and proximal tibia fractures.
One site will be involved in this study. The aim is to include a maximum of 112 consecutive series cases who received the Zimmer® Plates and Screws System at the Istituto Ortopedico Rizzoli (Bologna, Italy) between 2008 and 2018. All potential...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients having received one of the plates belonging to the Zimmer® Plates and Screws System, designed for temporary internal fixation to stabilize fractures during the normal healing process. In this study we will collect data specifically on Zimmer® Plates and Screws System plates belonging to the Diaphysis, Proximal Humerus and Proximal Tibia groups.
- Exclusion Criteria:
- • Off-label use
- • Patients under the age of 18
- • Prisoners
- • Severely comminuted fractures in which bone fragments are too small or numerous to adequately fix or maintain a reduced position
- • Infection
- • Metal sensitivity or intolerance
- • Severe osteopenia and/or osteoporosis, or in the presence of marked or rapid bone absorption, metabolic bone disease, cancer, or any other tumor-like condition of the bone which may compromise fixation
- • Sternal or spinal fractures
- • Anatomical location in which the device would interfere with nerves, blood vessels, or other vital structures
- • Patients with inadequate soft tissue coverage at the implant site
About Zimmer Biomet
Zimmer Biomet is a leading global medical technology company specializing in the design, development, and manufacturing of innovative orthopedic and surgical products. With a commitment to enhancing patient outcomes, Zimmer Biomet focuses on advancing musculoskeletal health through a broad range of solutions, including joint reconstruction, surgical instrumentation, and dental implants. The company emphasizes research and development, conducting numerous clinical trials to evaluate the safety and effectiveness of its products, while fostering collaboration with healthcare professionals to address the evolving needs of patients and providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Hassan Achakri
Study Director
Zimmer Biomet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials